EA202092017A1 - NEW GLP-1 ANALOGUES - Google Patents
NEW GLP-1 ANALOGUESInfo
- Publication number
- EA202092017A1 EA202092017A1 EA202092017A EA202092017A EA202092017A1 EA 202092017 A1 EA202092017 A1 EA 202092017A1 EA 202092017 A EA202092017 A EA 202092017A EA 202092017 A EA202092017 A EA 202092017A EA 202092017 A1 EA202092017 A1 EA 202092017A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- analogs
- present
- glp
- action
- analogues
- Prior art date
Links
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Abstract
Настоящее изобретение относится к новым аналогам глюкагоноподобного пептида-1 (GLP-1) (7-37), имеющим аминокислотную последовательность с Leu или Ile на C-конце. Новые аналоги являются высокоактивными агонистами GLP-1 со сниженным количеством нежелательных эффектов и увеличенной продолжительностью действия. Настоящее изобретение также относится к ацилированным производным новых аналогов, которые характеризуются дополнительно увеличенной активностью и продолжительностью действия и подходят для перорального введения. Аналоги по настоящему изобретению могут найти применение в лечении диабета и ожирения.The present invention relates to novel analogs of glucagon-like peptide-1 (GLP-1) (7-37) having the amino acid sequence with Leu or Ile at the C-terminus. The new analogs are highly active GLP-1 agonists with reduced unwanted effects and increased duration of action. The present invention also relates to acylated derivatives of the novel analogs which are further enhanced in activity and duration of action and are suitable for oral administration. The analogs of the present invention may find use in the treatment of diabetes and obesity.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN201821040474 | 2018-10-26 | ||
PCT/IB2019/052835 WO2019193576A1 (en) | 2018-04-05 | 2019-04-05 | Novel glp-1 analogues |
Publications (1)
Publication Number | Publication Date |
---|---|
EA202092017A1 true EA202092017A1 (en) | 2021-02-10 |
Family
ID=74855471
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA202092017A EA202092017A1 (en) | 2018-10-26 | 2019-04-05 | NEW GLP-1 ANALOGUES |
Country Status (1)
Country | Link |
---|---|
EA (1) | EA202092017A1 (en) |
-
2019
- 2019-04-05 EA EA202092017A patent/EA202092017A1/en unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA202306729B (en) | Novel glp-1 analogues | |
EA202090392A3 (en) | GIP AND GLP-1 COAGONIST COMPOUNDS | |
MY197569A (en) | Gip/glp1 co-agonist compounds | |
EA202192588A1 (en) | PHARMACEUTICAL COMPOSITION INCLUDING PH20 VARIANT OF HUMAN HYALURONIDASE AND DRUG FOR SUBCUTANEOUS ADMINISTRATION | |
EA201991345A1 (en) | NEW COMPOUNDS AS PEPTIDE TRIPLE GLP1 / GLUCAGON / GIP RECEPTOR AGONISTS | |
EA201690660A1 (en) | CONNECTIONS AND METHODS BASED ON DOUBLE AGONIST OF GIP AND GLP-1 | |
PE20200606A1 (en) | SOLID COMPOSITIONS FOR ORAL ADMINISTRATION | |
RU2015101697A (en) | GLUCAGON ANALOGUES WITH GIP RECEPTOR ACTIVITY | |
JP2014504588A5 (en) | ||
PE20090932A1 (en) | COMPOUNDS THAT EXHIBIT GLUCAGON ANTAGONIST AND GLP-1 AGONIST ACTIVITY | |
AR094181A1 (en) | GLP1 / GIP OR TRIGONAL DUAL AGONISTS OF GLP1 / GIP / GLUCAGON | |
EA201270723A1 (en) | NEW PEPTIDES AND METHODS FOR THEIR RECEPTION AND APPLICATION | |
CO6280539A2 (en) | MIXED AGONISTS, BASED ON GIP FOR THE TREATMENT OF METABOLIC DISORDERS AND OBESITY | |
PE20120563A1 (en) | NOVEL CONSTRUCTIONS OF HUMAN PAPILLOMA VIRUS (HPV) PROTEIN AND ITS USE IN THE PREVENTION OF HPV DISEASE | |
AR067555A1 (en) | DERIVATIVE OF INSULINOTROPIC PEPTIDE IN WHICH THE N-TERMINAL AMINO ACID IS MODIFIED | |
GT201700224A (en) | RGMA BINDING PROTEIN AND ITS USE | |
JP2018504901A5 (en) | ||
MX2020008387A (en) | Therapeutic uses of glp1r agonists. | |
EA202091095A1 (en) | ORAL DELIVERY OF GLP-1 PEPTIDE ANALOGUES | |
MX2022009149A (en) | Gip/glp1 co-agonist compounds. | |
EA200800181A1 (en) | PHARMACEUTICAL COMPOSITION GLP-1 | |
MX2020001761A (en) | Acylated oxyntomodulin peptide analog. | |
PH12021551243A1 (en) | Oxyntomodulin peptide analog formulations | |
EA202092017A1 (en) | NEW GLP-1 ANALOGUES | |
PE20221518A1 (en) | INCRETIN ANALOGS AND THEIR USES |